Liraglutide, marketed under the brand name Victoza, is a medication used for treating type 2 diabetes and obesity. When compared to metformin, it is a less preferred agent in the treatment of diabetes. | Semaglutide, also known as Ozempic and Rybelsus, is an anti-diabetic medication used to treat type 2 diabetes. Semaglutide functions similarly to human glucagon-like peptide-1 in that it increases insulin secretion and thus sugar metabolism. |
Liraglutide is used to control high blood sugar levels, either alone or in combination with other medications | Semaglutide is used for controlling high blood sugar in people who have type 2 diabetes. |
It works by increasing insulin release in response to high blood sugar levels (such as after a meal) and decreasing the amount of sugar produced by your liver. | When blood sugar levels are high, it helps the pancreas release the appropriate amount of insulin. Insulin aids in the transport of sugar from the bloodstream to other body tissues where it is used for energy. |
Disclaimer: The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.